About Universitat Autònoma de Barcelona
A new genotyping tool for detecting inversions in the human genome potentially associated with disease is being developed by the comparative and functional genomics group of the Universitat Autònoma de Barcelona (UAB). Together with the UAB Technology Transfer Office, the team is now looking to commercialize the approach and expand its use to many indications.
State of Ownership
CEO & Co-Founder, Zapnito
Business Development Executive, Nature Publishing Group
Chief Product Officer, Zapnito
Former Head of Communities, Springer Nature
Sales Account Executive, Springer Nature